ARTICLE | Clinical News
Formoterol Modulite regulatory update
February 2, 2009 8:00 AM UTC
EMEA's CHMP recommended against use of Chiesi's formoterol 12 µg to treat asthma in children ages 5-12 years because efficacy could not be demonstrated in the age group. The formoterol hydrofluoroalka...